Asphyxia Epidemiology Forecast 2026-2035

Asphyxia is a life-threatening condition caused by inadequate oxygen supply to the body, leading to impaired breathing and organ damage. As per Yuanping Wang et al., 2025, neonatal asphyxia remains a major global health burden. According to the World Health Organization, nearly 800,000 newborns die annually, accounting for about 23% of global neonatal deaths, with higher prevalence in low- and middle-income countries. According to the asphyxia epidemiology forecast, the disease burden is expected to remain significant worldwide.

Asphyxia Epidemiology Forecast Report Coverage

The analyst's “Asphyxia Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of asphyxia. It projects the future incidence and prevalence rates of asphyxia cases across various populations. The study covers age, gender, and type as major determinants of the asphyxia population. The report highlights patterns in the prevalence of asphyxia over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of asphyxia in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Asphyxia Understanding: Disease Overview

Asphyxia is a life-threatening condition characterized by inadequate oxygen supply to the body, resulting in impaired cellular respiration and potential organ damage. It occurs when oxygen delivery to tissues is reduced or when carbon dioxide removal is hindered, commonly due to airway obstruction, suffocation, drowning, choking, or exposure to toxic gases. Asphyxia disrupts normal physiological processes and can rapidly lead to unconsciousness or death if untreated. Major types include mechanical asphyxia (such as strangulation or choking), chemical asphyxia caused by toxic substances, and neonatal asphyxia, also known as birth asphyxia, which occurs when a newborn experiences oxygen deprivation during or immediately after delivery.

Asphyxia Epidemiology Perspective

The asphyxia epidemiology division offers information on the patient pool from history to the present, as well as the projected trend for each of the 8 major markets. The analyst provides both current and predicted trends for the asphyxia epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for asphyxia and its trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• According to Yu-Jie Su et al., 2024, perinatal asphyxia remains a major global contributor to neonatal morbidity and mortality, accounting for nearly 25% of neonatal deaths among about 4 million annual births worldwide, highlighting its substantial epidemiological burden in early life.
• As per Irene Eseohe Akhigbe et al., 2025, the highest mortality risk occurs within the first month of life, with approximately 2.3 million global neonatal deaths in 2022, and nearly 75% occurring during the first week, often linked to birth complications including perinatal asphyxia.
• According to Hrishabh Soni et al., 2025, hospital-based observations reported 130 cases of birth asphyxia among 2,770 neonatal intensive care unit admissions (4.7%), demonstrating its significant incidence in neonatal care settings and its continued impact on neonatal morbidity.
• As per Hrishabh Soni et al., 2025, male neonates represented about 60.8% of birth asphyxia cases, suggesting a slight gender predominance, while maternal characteristics such as younger maternal age and anemia were frequently observed among affected neonatal populations.

Country-wise Asphyxia Epidemiology

The asphyxia epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Across major healthcare markets, the epidemiology of asphyxia shows notable regional variation. According to Kisito Nagalo et al., 2024, in France the incidence of perinatal asphyxia is approximately 3 per 1,000 live births in the Pas-de-Calais region, while India reports higher rates, with around 21.2% of cases among hospitalized neonates. According to Hrishabh Soni et al., 2025, birth asphyxia contributes to nearly 20% of neonatal deaths in India. In Spain, according to Yu-Jie Su et al., 2024, severe asphyxia leads to hypoxic-ischemic encephalopathy in about 25.6% of affected children. Meanwhile, the United States, United Kingdom, Germany, Italy, and Japan generally report lower incidence due to advanced neonatal care and surveillance systems.

Asphyxia: Treatment Overview

Asphyxia treatment focuses on rapidly restoring oxygen supply and maintaining vital organ function. Immediate emergency management includes clearing the airway, providing cardiopulmonary resuscitation (CPR) when necessary, and administering supplemental oxygen through masks or ventilation devices. In severe cases, advanced airway management such as endotracheal intubation or mechanical ventilation may be required. For chemical asphyxia, removal from the toxic environment and administration of specific antidotes may be necessary. In neonatal asphyxia, prompt neonatal resuscitation, oxygen therapy, and supportive intensive care are essential. Continuous monitoring and management of complications such as brain injury or respiratory failure are also critical components of treatment.

Key Questions Answered

• What are the key findings of asphyxia epidemiology in the 8 major markets?
• What will be the total number of patients with asphyxia across the 8 major markets during the forecast period?
• What was the country-wise asphyxia epidemiology scenario in the 8 major markets in the historical period?
• Which country will have the highest number of asphyxia patients during the forecast period of 2026-2035?
• Which key factors would influence the shift in the patient population of asphyxia during the forecast period of 2026-2035?
• What are the currently available treatments for asphyxia?
• What are the disease risks, signs, symptoms, and unmet needs of asphyxia?

Scope of the Asphyxia Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of asphyxia based on several factors.
• Asphyxia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The asphyxia report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.